Comparison of salivary concentrations of rifampin and cefaclor: a rationale for chemoprophylaxis of Hemophilus influenzae type b disease.
D000328:Adult; D002433:Cefaclor / Q000008:administration & dosage / Q000627:therapeutic use*; D002506:Cephalexin / Q000031:analogs & derivatives*; D004341:Drug Evaluation; D006192:Haemophilus Infections / Q000517:prevention & control*; D006193:Haemophilus influenzae; D006801:Humans; D008297:Male; D008828:Microbiological Techniques; D008875:Middle Aged; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use*; D012463:Saliva / Q000032:analysis* / Q000382:microbiology; D013535:Suspensions; D013607:Tablets; D013997:Time Factors
D013535:Suspensions; D013607:Tablets; D002433:Cefaclor; D002506:Cephalexin; D012293:Rifampin